ExploreOutcomePercentage of total
Outcome

Percentage of total

Also known as: % of total % of total (qualifier value) % total Percentage of total Percentage of total (qualifier value) Percentage of weeks with (hypo)manic symptoms over 2 years Percentage of weeks with depressive symptoms over 2 years percent of total
6 findings 1 paper 5 related entities View in graph →

Related entities

interventions
conditions
populations
studys

Findings (50)

None
decline

Adolescents with bipolar disorder and comorbid anxiety spent a significantly greater percentage of time with depressive symptoms over 2 years compared to those without comorbid anxiety.

Effect: decline; 47.8% (SD=27.5) vs 34.3% (SD=26.8)

Size: 47.8% (SD=27.5) vs 34.3% (SD=26.8)
None
decline

Adolescents with bipolar disorder and comorbid anxiety spent a significantly greater percentage of time with depressive symptoms over 2 years compared to those without comorbid anxiety.

Effect: decline; 47.8% (SD=27.5) vs 34.3% (SD=26.8)

Size: 47.8% (SD=27.5) vs 34.3% (SD=26.8)
None
decline

Adolescents with bipolar disorder and comorbid anxiety spent a significantly greater percentage of time with depressive symptoms over 2 years compared to those without comorbid anxiety.

Effect: decline; 47.8% (SD=27.5) vs 34.3% (SD=26.8)

Size: 47.8% (SD=27.5) vs 34.3% (SD=26.8)
None
decline

Adolescents with bipolar disorder and comorbid anxiety spent a significantly greater percentage of time with depressive symptoms over 2 years compared to those without comorbid anxiety.

Effect: decline; 47.8% (SD=27.5) vs 34.3% (SD=26.8)

Size: 47.8% (SD=27.5) vs 34.3% (SD=26.8)
None
decline

Adolescents with bipolar disorder and comorbid anxiety spent a significantly greater percentage of time with depressive symptoms over 2 years compared to those without comorbid anxiety.

Effect: decline; 47.8% (SD=27.5) vs 34.3% (SD=26.8)

Size: 47.8% (SD=27.5) vs 34.3% (SD=26.8)
None
decline

Adolescents with bipolar disorder and comorbid anxiety spent a significantly greater percentage of time with depressive symptoms over 2 years compared to those without comorbid anxiety.

Effect: decline; 47.8% (SD=27.5) vs 34.3% (SD=26.8)

Size: 47.8% (SD=27.5) vs 34.3% (SD=26.8)
None
decline

Adolescents with bipolar disorder and comorbid anxiety spent a significantly greater percentage of time with depressive symptoms over 2 years compared to those without comorbid anxiety.

Effect: decline; 47.8% (SD=27.5) vs 34.3% (SD=26.8)

Size: 47.8% (SD=27.5) vs 34.3% (SD=26.8)
None
decline

Adolescents with bipolar disorder and comorbid anxiety spent a significantly greater percentage of time with depressive symptoms over 2 years compared to those without comorbid anxiety.

Effect: decline; 47.8% (SD=27.5) vs 34.3% (SD=26.8)

Size: 47.8% (SD=27.5) vs 34.3% (SD=26.8)
None
decline

Adolescents with bipolar disorder and comorbid anxiety spent a significantly greater percentage of time with depressive symptoms over 2 years compared to those without comorbid anxiety.

Effect: decline; 47.8% (SD=27.5) vs 34.3% (SD=26.8)

Size: 47.8% (SD=27.5) vs 34.3% (SD=26.8)
None
decline

Adolescents with bipolar disorder and comorbid anxiety spent a significantly greater percentage of time with depressive symptoms over 2 years compared to those without comorbid anxiety.

Effect: decline; 47.8% (SD=27.5) vs 34.3% (SD=26.8)

Size: 47.8% (SD=27.5) vs 34.3% (SD=26.8)
None
decline

Adolescents with bipolar disorder and comorbid anxiety spent a significantly greater percentage of time with depressive symptoms over 2 years compared to those without comorbid anxiety.

Effect: decline; 47.8% (SD=27.5) vs 34.3% (SD=26.8)

Size: 47.8% (SD=27.5) vs 34.3% (SD=26.8)
None
decline

Adolescents with bipolar disorder and comorbid anxiety spent a significantly greater percentage of time with depressive symptoms over 2 years compared to those without comorbid anxiety.

Effect: decline; 47.8% (SD=27.5) vs 34.3% (SD=26.8)

Size: 47.8% (SD=27.5) vs 34.3% (SD=26.8)
None
decline

Adolescents with bipolar disorder and comorbid anxiety spent a significantly greater percentage of time with depressive symptoms over 2 years compared to those without comorbid anxiety.

Effect: decline; 47.8% (SD=27.5) vs 34.3% (SD=26.8)

Size: 47.8% (SD=27.5) vs 34.3% (SD=26.8)
None
decline

Adolescents with bipolar disorder and comorbid anxiety spent a significantly greater percentage of time with depressive symptoms over 2 years compared to those without comorbid anxiety.

Effect: decline; 47.8% (SD=27.5) vs 34.3% (SD=26.8)

Size: 47.8% (SD=27.5) vs 34.3% (SD=26.8)
None
decline

Adolescents with bipolar disorder and comorbid anxiety spent a significantly greater percentage of time with depressive symptoms over 2 years compared to those without comorbid anxiety.

Effect: decline; 47.8% (SD=27.5) vs 34.3% (SD=26.8)

Size: 47.8% (SD=27.5) vs 34.3% (SD=26.8)
None
decline

Adolescents with bipolar disorder and comorbid anxiety spent a significantly greater percentage of time with depressive symptoms over 2 years compared to those without comorbid anxiety.

Effect: decline; 47.8% (SD=27.5) vs 34.3% (SD=26.8)

Size: 47.8% (SD=27.5) vs 34.3% (SD=26.8)
None
decline

Adolescents with bipolar disorder and comorbid anxiety spent a significantly greater percentage of time with depressive symptoms over 2 years compared to those without comorbid anxiety.

Effect: decline; 47.8% (SD=27.5) vs 34.3% (SD=26.8)

Size: 47.8% (SD=27.5) vs 34.3% (SD=26.8)
None
decline

Adolescents with bipolar disorder and comorbid anxiety spent a significantly greater percentage of time with depressive symptoms over 2 years compared to those without comorbid anxiety.

Effect: decline; 47.8% (SD=27.5) vs 34.3% (SD=26.8)

Size: 47.8% (SD=27.5) vs 34.3% (SD=26.8)
None
decline

Adolescents with bipolar disorder and comorbid anxiety spent a significantly greater percentage of time with depressive symptoms over 2 years compared to those without comorbid anxiety.

Effect: decline; 47.8% (SD=27.5) vs 34.3% (SD=26.8)

Size: 47.8% (SD=27.5) vs 34.3% (SD=26.8)
None
decline

Adolescents with bipolar disorder and comorbid anxiety spent a significantly greater percentage of time with depressive symptoms over 2 years compared to those without comorbid anxiety.

Effect: decline; 47.8% (SD=27.5) vs 34.3% (SD=26.8)

Size: 47.8% (SD=27.5) vs 34.3% (SD=26.8)
None
decline

Adolescents with bipolar disorder and comorbid anxiety spent a significantly greater percentage of time with depressive symptoms over 2 years compared to those without comorbid anxiety.

Effect: decline; 47.8% (SD=27.5) vs 34.3% (SD=26.8)

Size: 47.8% (SD=27.5) vs 34.3% (SD=26.8)
None
decline

Adolescents with bipolar disorder and comorbid anxiety spent a significantly greater percentage of time with depressive symptoms over 2 years compared to those without comorbid anxiety.

Effect: decline; 47.8% (SD=27.5) vs 34.3% (SD=26.8)

Size: 47.8% (SD=27.5) vs 34.3% (SD=26.8)
None
decline

Adolescents with bipolar disorder and comorbid anxiety spent a significantly greater percentage of time with depressive symptoms over 2 years compared to those without comorbid anxiety.

Effect: decline; 47.8% (SD=27.5) vs 34.3% (SD=26.8)

Size: 47.8% (SD=27.5) vs 34.3% (SD=26.8)
None
decline

Adolescents with bipolar disorder and comorbid anxiety spent a significantly greater percentage of time with depressive symptoms over 2 years compared to those without comorbid anxiety.

Effect: decline; 47.8% (SD=27.5) vs 34.3% (SD=26.8)

Size: 47.8% (SD=27.5) vs 34.3% (SD=26.8)
None
decline

Adolescents with bipolar disorder and comorbid anxiety spent a significantly greater percentage of time with depressive symptoms over 2 years compared to those without comorbid anxiety.

Effect: decline; 47.8% (SD=27.5) vs 34.3% (SD=26.8)

Size: 47.8% (SD=27.5) vs 34.3% (SD=26.8)
None
decline

Adolescents with bipolar disorder and comorbid anxiety spent a significantly greater percentage of time with depressive symptoms over 2 years compared to those without comorbid anxiety.

Effect: decline; 47.8% (SD=27.5) vs 34.3% (SD=26.8)

Size: 47.8% (SD=27.5) vs 34.3% (SD=26.8)
None
decline

Adolescents with bipolar disorder and comorbid anxiety spent a significantly greater percentage of time with depressive symptoms over 2 years compared to those without comorbid anxiety.

Effect: decline; 47.8% (SD=27.5) vs 34.3% (SD=26.8)

Size: 47.8% (SD=27.5) vs 34.3% (SD=26.8)
None
decline

Adolescents with bipolar disorder and comorbid ADHD spent a significantly greater percentage of time with (hypo)manic symptoms over 2 years compared to those without ADHD.

Effect: decline; 31.8% (SD=26.2) vs 19.4% (SD=20.0)

Size: 31.8% (SD=26.2) vs 19.4% (SD=20.0)
None
decline

Adolescents with bipolar disorder and comorbid ADHD spent a significantly greater percentage of time with (hypo)manic symptoms over 2 years compared to those without ADHD.

Effect: decline; 31.8% (SD=26.2) vs 19.4% (SD=20.0)

Size: 31.8% (SD=26.2) vs 19.4% (SD=20.0)
None
decline

Adolescents with bipolar disorder and comorbid ADHD spent a significantly greater percentage of time with (hypo)manic symptoms over 2 years compared to those without ADHD.

Effect: decline; 31.8% (SD=26.2) vs 19.4% (SD=20.0)

Size: 31.8% (SD=26.2) vs 19.4% (SD=20.0)
None
decline

Adolescents with bipolar disorder and comorbid ADHD spent a significantly greater percentage of time with (hypo)manic symptoms over 2 years compared to those without ADHD.

Effect: decline; 31.8% (SD=26.2) vs 19.4% (SD=20.0)

Size: 31.8% (SD=26.2) vs 19.4% (SD=20.0)
None
decline

Adolescents with bipolar disorder and comorbid ADHD spent a significantly greater percentage of time with (hypo)manic symptoms over 2 years compared to those without ADHD.

Effect: decline; 31.8% (SD=26.2) vs 19.4% (SD=20.0)

Size: 31.8% (SD=26.2) vs 19.4% (SD=20.0)
None
decline

Adolescents with bipolar disorder and comorbid ADHD spent a significantly greater percentage of time with (hypo)manic symptoms over 2 years compared to those without ADHD.

Effect: decline; 31.8% (SD=26.2) vs 19.4% (SD=20.0)

Size: 31.8% (SD=26.2) vs 19.4% (SD=20.0)
None
decline

Adolescents with bipolar disorder and comorbid ADHD spent a significantly greater percentage of time with (hypo)manic symptoms over 2 years compared to those without ADHD.

Effect: decline; 31.8% (SD=26.2) vs 19.4% (SD=20.0)

Size: 31.8% (SD=26.2) vs 19.4% (SD=20.0)
None
decline

Adolescents with bipolar disorder and comorbid ADHD spent a significantly greater percentage of time with (hypo)manic symptoms over 2 years compared to those without ADHD.

Effect: decline; 31.8% (SD=26.2) vs 19.4% (SD=20.0)

Size: 31.8% (SD=26.2) vs 19.4% (SD=20.0)
None
decline

Adolescents with bipolar disorder and comorbid ADHD spent a significantly greater percentage of time with (hypo)manic symptoms over 2 years compared to those without ADHD.

Effect: decline; 31.8% (SD=26.2) vs 19.4% (SD=20.0)

Size: 31.8% (SD=26.2) vs 19.4% (SD=20.0)
None
decline

Adolescents with bipolar disorder and comorbid ADHD spent a significantly greater percentage of time with (hypo)manic symptoms over 2 years compared to those without ADHD.

Effect: decline; 31.8% (SD=26.2) vs 19.4% (SD=20.0)

Size: 31.8% (SD=26.2) vs 19.4% (SD=20.0)
None
decline

Adolescents with bipolar disorder and comorbid ADHD spent a significantly greater percentage of time with (hypo)manic symptoms over 2 years compared to those without ADHD.

Effect: decline; 31.8% (SD=26.2) vs 19.4% (SD=20.0)

Size: 31.8% (SD=26.2) vs 19.4% (SD=20.0)
None
decline

Adolescents with bipolar disorder and comorbid ADHD spent a significantly greater percentage of time with (hypo)manic symptoms over 2 years compared to those without ADHD.

Effect: decline; 31.8% (SD=26.2) vs 19.4% (SD=20.0)

Size: 31.8% (SD=26.2) vs 19.4% (SD=20.0)
None
decline

Adolescents with bipolar disorder and comorbid ADHD spent a significantly greater percentage of time with (hypo)manic symptoms over 2 years compared to those without ADHD.

Effect: decline; 31.8% (SD=26.2) vs 19.4% (SD=20.0)

Size: 31.8% (SD=26.2) vs 19.4% (SD=20.0)
None
decline

Adolescents with bipolar disorder and comorbid ADHD spent a significantly greater percentage of time with (hypo)manic symptoms over 2 years compared to those without ADHD.

Effect: decline; 31.8% (SD=26.2) vs 19.4% (SD=20.0)

Size: 31.8% (SD=26.2) vs 19.4% (SD=20.0)
None
decline

Adolescents with bipolar disorder and comorbid ADHD spent a significantly greater percentage of time with (hypo)manic symptoms over 2 years compared to those without ADHD.

Effect: decline; 31.8% (SD=26.2) vs 19.4% (SD=20.0)

Size: 31.8% (SD=26.2) vs 19.4% (SD=20.0)
None
decline

Adolescents with bipolar disorder and comorbid ADHD spent a significantly greater percentage of time with (hypo)manic symptoms over 2 years compared to those without ADHD.

Effect: decline; 31.8% (SD=26.2) vs 19.4% (SD=20.0)

Size: 31.8% (SD=26.2) vs 19.4% (SD=20.0)
None
decline

Adolescents with bipolar disorder and comorbid ADHD spent a significantly greater percentage of time with (hypo)manic symptoms over 2 years compared to those without ADHD.

Effect: decline; 31.8% (SD=26.2) vs 19.4% (SD=20.0)

Size: 31.8% (SD=26.2) vs 19.4% (SD=20.0)
None
decline

Adolescents with bipolar disorder and comorbid ADHD spent a significantly greater percentage of time with (hypo)manic symptoms over 2 years compared to those without ADHD.

Effect: decline; 31.8% (SD=26.2) vs 19.4% (SD=20.0)

Size: 31.8% (SD=26.2) vs 19.4% (SD=20.0)
None
decline

Adolescents with bipolar disorder and comorbid ADHD spent a significantly greater percentage of time with (hypo)manic symptoms over 2 years compared to those without ADHD.

Effect: decline; 31.8% (SD=26.2) vs 19.4% (SD=20.0)

Size: 31.8% (SD=26.2) vs 19.4% (SD=20.0)
None
decline

Adolescents with bipolar disorder and comorbid ADHD spent a significantly greater percentage of time with (hypo)manic symptoms over 2 years compared to those without ADHD.

Effect: decline; 31.8% (SD=26.2) vs 19.4% (SD=20.0)

Size: 31.8% (SD=26.2) vs 19.4% (SD=20.0)
None
decline

Adolescents with bipolar disorder and comorbid ADHD spent a significantly greater percentage of time with (hypo)manic symptoms over 2 years compared to those without ADHD.

Effect: decline; 31.8% (SD=26.2) vs 19.4% (SD=20.0)

Size: 31.8% (SD=26.2) vs 19.4% (SD=20.0)
None
decline

Adolescents with bipolar disorder and comorbid ADHD spent a significantly greater percentage of time with (hypo)manic symptoms over 2 years compared to those without ADHD.

Effect: decline; 31.8% (SD=26.2) vs 19.4% (SD=20.0)

Size: 31.8% (SD=26.2) vs 19.4% (SD=20.0)
None
decline

Adolescents with bipolar disorder and comorbid ADHD spent a significantly greater percentage of time with (hypo)manic symptoms over 2 years compared to those without ADHD.

Effect: decline; 31.8% (SD=26.2) vs 19.4% (SD=20.0)

Size: 31.8% (SD=26.2) vs 19.4% (SD=20.0)

Papers (1)